0001209191-21-002831.txt : 20210108 0001209191-21-002831.hdr.sgml : 20210108 20210108192846 ACCESSION NUMBER: 0001209191-21-002831 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210106 FILED AS OF DATE: 20210108 DATE AS OF CHANGE: 20210108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stankovic Srdjan R. CENTRAL INDEX KEY: 0001432545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 21518780 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-06 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001432545 Stankovic Srdjan R. C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 President Common Stock 2021-01-06 4 M 0 5444 A 21972 D Common Stock 2021-01-06 4 S 0 1725 53.34 D 20247 D Common Stock 2021-01-07 4 M 0 61619 35.80 A 81866 D Common Stock 2021-01-07 4 S 0 61619 55.1159 D 20247 D Common Stock 2021-01-08 4 M 0 13381 35.80 A 33628 D Common Stock 2021-01-08 4 M 0 12864 21.28 A 46492 D Common Stock 2021-01-08 4 M 0 3488 18.12 A 49980 D Common Stock 2021-01-08 4 S 0 29733 55.2192 D 20247 D Restricted Stock Units 2021-01-06 4 M 0 5444 0.00 D Common Stock 5444 16333 D Stock Option (Right to Buy) 35.80 2021-01-06 4 M 0 61619 0.00 D 2027-09-06 Common Stock 61619 69631 D Stock Option (Right to Buy) 35.80 2021-01-08 4 M 0 13381 0.00 D 2027-09-06 Common Stock 13381 56250 D Stock Option (Right to Buy) 21.28 2021-01-08 4 M 0 12864 0.00 D 2028-10-14 Common Stock 12864 22761 D Stock Option (Right to Buy) 18.12 2021-01-08 4 M 0 3488 0.00 D 2028-11-18 Common Stock 3488 90262 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in four equal annual installments beginning January 6, 2021. 25% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. 25% of the shares subject to the Stock Option vested and became exercisable on October 15, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. 25% of the shares subject to the Stock Option vested and became exercisable on November 19, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. /s/ Austin D. Kim, Attorney-in-Fact 2021-01-08